In breast cancer, ectopic introduction of the phosphomimic mutant of WBP2 (Y192E, Y231E) was more efficacious in promoting WBP2 nuclear accumulation and the transcriptional activity of ER and β catenin [61]. This evidence concerns the gene WBP2 and breast cancer.